Home Blog Page 238

Blog

Pharma Marketing Blog

Random

Are Secret Drug Recalls Common?

Pharma Guy - September 21, 2010

Was Lilly’s #mmeds Twitter Chat a Discussion or a Press Conference?

Pharma Guy - October 14, 2011

Are Pharma Marketers Drug Pushers?

Pharma Guy - March 25, 2010

Back to School for Takeda, Rozerem, and Abe Lincoln!

Pharma Guy - March 9, 2007

FDA’s “Off-Label Risk Reduction” Approach to Reprint Distribution is “Misguided,” Says...

Pharma Guy - August 15, 2014

Laptop on top of desk with google on the home screen

Unlocking the Potential of Digital Marketing in Pharma: A Comprehensive Guide

Claudia Barbiero - September 19, 2023

PhRMA Should Have Listened to THIS “Guy in a Hoodie”

Pharma Guy - January 25, 2017

AZ: Let’s Put a Positive Spin on this “Cursed” Study

Pharma Guy - February 27, 2009

Pharma PAC Donations to McCain Increasing Faster Than Donations to Obama

Pharma Guy - October 8, 2008

Is Online Pharma Promotion ROI Scalable?

Pharma Guy - October 17, 2012

1...237238239...241 Page 238 of 241

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

From Messaging to Meaning: Why Pharma Marketing Needs a Stronger Point...

April 17, 2026

Stopwatch with pharmaceutical products and analytics dashboard representing speed in pharma marketing

The Velocity Problem: When Pharma Marketing Moves Slower Than the Market

April 17, 2026

Pharmaceutical marketing concept showing hidden stakeholders like policymakers, media, and algorithms influencing healthcare decisions

Invisible Audiences: The Stakeholders Pharma Marketing Ignores at Its Own Risk

April 16, 2026